作者: Jie Gao , Jing Sun , Huimei Li , Wei Liu , Yang Zhang
DOI: 10.1016/J.BIOMATERIALS.2009.11.112
关键词:
摘要: The development of a tumor-specific immunoliposome delivering small interfering RNA (siRNA) represents practical way in cancer gene therapy. In this study, we developed PEGylated 3beta-[N-(N', N'-dimethylaminoethane) carbamoyl] cholesterol (DC-Chol)/dioleoylphosphatidyl ethanolamine (DOPE) immunoliposomes conjugated with the Fab' recombinant humanized anti-HER2 monoclonal antibody (PIL) for siRNA delivery. results demonstrated that lyophilized PIL (LPIL) prepared by lyophilization/rehydration method possessed significantly enhanced HER1 gene, model target, silencing ability compared HER2-overexpressing SK-BR3 cells. Among series LPIL different PEGylation degree, containing 2.5%PEG (2.5%PEG LPIL) showed best activity. Confocal microscope studies could specifically bind to cells and were sequentially internalized into them. Using RhoA as therapeutic entrapping anti-RhoA silence expression inhibit cell invasion conclusion, these finding potential use cancers.